Allurion Technologies sees Q4 revenue $8.1M-$8.4M

Sees FY23 revenue in the range of $53M – $54M with gross profit sustained at 77% – 78% of revenue..Fourth quarter revenue is expected to be in the range of $8.1 – $8.3M, reflecting macroeconomic headwinds in certain markets leading to temporarily lower re-order rates during the period as distributors and accounts in certain markets adjusted their inventory levels;Procedural volume grew by 30% compared to 2022, reflecting strong and growing demand for the Allurion Program, particularly in Europe where procedural volume grew by 41% in 2023 compared to 2022 and 44% in the fourth quarter compared to the same period in 2022;Cash balance as of December 31 of $38M reflects cash burn of $22M in the fourth quarter and paydown of the term loan by $20M, reducing outstanding principal to $40MExpense reductions initiated in the fourth quarter of 2023 and continued in 2024 include a reduction in force of approximately 30% of headcount since December 2023, which is expected to reduce 2024 cash burn to approximately $7 – $8M per quarter…